Keyword: biologics


Kyowa Kirin to Establish New Biologics Manufacturing Plant in US

13.06.2024 -

Kyowa Kirin announced a new, state-of-the-art manufacturing facility in Sanford, North Carolina, US. Kyowa Kirin will invest up to $530 million (€489 million) in...


Aurigene Opens Biologics Facility

05.06.2024 -

Aurigene Pharmaceutical Services Limited (Aurigene), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 6500 m2 (70,000 sq ft)...


Sanofi Invests €1 Billion to Boost Drug Manufacturing in France

14.05.2024 -

On Monday, Paris-based French drugmaker Sanofi announced plans to invest more than €1 billion at three facilities in France to create new bioproduction capacity.


Wacker Expands Production Capacity for Biopharmaceuticals in San Diego

08.05.2024 -

Contract manufacturing and development organization (CDMO) Wacker Biotech US, a subsidiary of Germany’ Wacker Chemie specializing in the fermentative production of...


Aragen Launches First Phase of Biologics Facility in India

28.03.2024 -

Aragen, a CRDMO, has launched the first phase of its biologics manufacturing facility in Bangalore, India. The $30 million project, executed by its subsidiary Aragen...


Lonza Buys Biologics Plant From Roche for $1.2 Billion

21.03.2024 -

Lonza has signed an agreement to acquire Genentech's biologics manufacturing site in Vacaville, California (USA) from Roche. The Swiss pharmaceutical company announced...


Kyowa Kirin to Build First US Pharma Operations

12.03.2024 -

Japan-based pharmaceutical company Kyowa Kirin plans to build a $200 million biologics manufacturing center in Sanford, North Carolina, creating 102 jobs. This will be...


AbbVie to Build New Biologics Manufacturing Site in Singapore

30.01.2024 -

Last week, AbbVie broke ground on a new Singapore manufacturing facility located in Singapore's Tuas Biomedical Park. The company will invest $223 million in the site...